Form 4: Bioventus Inc. SVP & CFO Mark Leonard Singleton Reports Sale of Shares to Cover Taxes

Mark Leonard Singleton, SVP & CFO of Bioventus Inc., sold 9,219 shares of Class A Common Stock to cover taxes upon the vesting of restricted stock units.

Summary

• On June 21, 2024, Mark Leonard Singleton, the SVP & CFO of Bioventus Inc., sold 9,219 shares of Class A Common Stock.
• The sale was executed at a weighted average price of $5.57 per share.
• The transaction was made to cover taxes upon the vesting of restricted stock units on June 20, 2024, pursuant to a standing 10b5-1 instruction adopted on June 20, 2023.
• Following the transaction, Singleton directly owns 84,895 shares of Bioventus Inc. Class A Common Stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction (sale of shares for tax purposes) by a company executive, which is neither particularly positive nor negative.

Industry Context

Sales of shares by company executives are common and often related to tax obligations or diversification strategies. The use of a 10b5-1 plan indicates that the sales were pre-planned and not based on insider information.

Comparison to Industry Standards

• Executive compensation packages often include restricted stock units that vest over time.
• Upon vesting, executives typically sell a portion of the shares to cover income tax obligations.
• The use of 10b5-1 trading plans is a standard practice to ensure compliance with insider trading regulations.
• Comparable companies such as Stryker, Zimmer Biomet, and Medtronic also see similar transactions by their executives.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's overall performance.

Key Dates